Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|November 1, 2025
RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressivenessEmanuele Vitale, Mila Gugnoni, Veronica Manicardi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2026
Histological subtype and receptor characteristics of cancers detected or missed by digital mammography and tomosynthesis: Results from MAITA randomized trialsPamela Mancuso, Moira Ragazzi, Isabella Castellano, et al.
Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4Michele Masetti, Giorgia Acquaviva, Michela Visani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2023
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast CancerFederica Miglietta, Moira Ragazzi, Bethania Fernandes, et al.
Pathologica|April 9, 2026
Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian projectBruna Cerbelli, Stefano Marletta, Michelina Amato, et al.
Pathologica|July 8, 2025
Consensus document on preoperative diagnostic procedures in breast lesionsStefano Marletta, Isabella Castellano, Francesca Caumo, et al.
Biomedicines|February 25, 2022
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, <i>BRCA</i>, <i>PTEN</i>, and Other GenesAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Nature Communications|February 24, 2019
Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responsesIvana Kurelac, Luisa Iommarini, Renaud Vatrinet, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Frontiers in Molecular Biosciences|March 7, 2025
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascitesIvana Kurelac, Manuela Sollazzo, Monica De Luise, et al.
Pageof 9